Key Biosimilars Market Players:
- Biocon Limited
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Amgen Inc.
- Novartis AG
- Intas Pharmaceuticals Ltd.
- BioXpress Therapeutics SA
- Genor Biopharma Co. Ltd
- Allergan plc (AbbVie Inc.)
- Coherus BioSciences, Inc.
- Pfizer Inc.
- Reliance Life Sciences Private Limited
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of biosimilars is evaluated at USD 32.55 billion.
Biosimilars Market size was over USD 28.61 billion in 2024 and is poised to exceed USD 128.4 billion by 2034, growing at over 16.2% CAGR during the forecast period i.e., between 2025-2034.
Europe is expected to dominate largest industry share by 2034.
The key market players include Biocon Limited, Amgen Inc., Novartis AG, Intas Pharmaceuticals Ltd., BioXpress Therapeutics SA, Genor Biopharma Co. Ltd, Allergan plc (AbbVie Inc.), Coherus BioSciences, Inc., Pfizer Inc., Reliance Life Sciences Private Limited.
